A Prospective Study for the Effects of Chronic Use of Doxazosin on Alpha 1-Adrenergic Receptors in Men With Benign Prostatic Hyperplasia.
Phase of Trial: Phase II
Latest Information Update: 25 Aug 2010
At a glance
- Drugs Doxazosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 25 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Aug 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.